Previous Close
$3.83
Day Range
$ - $
Previous Day Range
$ - $
Market Cap
$102.9 million USD
Day Vol.
Previous Day Vol.
Currency
USD
Primary Exchange
Nasdaq
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products includ...
Community
- 0 posts discussing
0
Watchers
0
Visitors